Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with modified Fc region, which can prolong its half-life. Nirsevimab has an affinity for RSV-B with an Kd value of 1.5 nM. Nirsevimab can be used for RSV research.
Purity:
>95.0%
CAS Number:
[1989556-22-0]
Target:
RSV
* VAT and and shipping costs not included. Errors and price changes excepted